1. Three point six nine one

   • Bernard Perbal

   EDITORIAL 20 August 2019 Pages: 269 - 270

2. A FAILED CANCER PARADIGM: implications for cancer risk assessment and patients

   • Edward J. Calabrese

   Commentary 05 August 2019 Pages: 271 - 272

3. Two decades (1998–2018) of research Progress on Hormesis: advancing biological understanding and enabling novel applications

   • Walter J. Kozumbo
   • Edward J. Calabrese

   Comment 17 April 2019 Pages: 273 - 275

   

4. Do drugs that target mTOR generate CCN2-mediated fibrogenic side effects?

   • Andrew Leask

   BITS AND BYTES 22 May 2019 Pages: 277 - 278

5. FGFR2-mediated phosphorylation of PTEN at tyrosine 240 contributes to the radioresistance of glioma

   • Yuanliang Yan
   • Zhi Li
   • Zhijie Xu

   Bits and Bytes 25 April 2019 Pages: 279 - 280

6. Chronic shisha exposure alters phosphoproteome of oral keratinocytes

   • Shankargouda Patil
   • Pavithra Rajagopalan
   • Marco Ferrari

   Nuts and Bolts 19 July 2019 Pages: 281 - 289

   

7. The endothelial tip-stalk cell selection and shuffling during angiogenesis

   • Wenqi Chen
   • Peng Xia
   • Lisha Li

   Review 22 March 2019 Pages: 291 - 301

   

8. Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response

   • Abhishek Mohanty
   • Rashmi Tiwari-Pandey
   • Nihar R. Pandey

   Review 04 February 2019 Pages: 303 - 318

   

9. Protein PEGylation for cancer therapy: bench to bedside

   • Vijayalaxmi Gupta
   • Sneha Bhavanasi
   • Sushanta K. Banerjee

   Review 29 November 2018 Pages: 319 - 330

   

10. Rsu1-dependent control of PTEN expression is regulated via ATF2 and cJun

    • Yong-Chul Kim
    • Reyda Gonzalez-Nieves
    • Mary L. Cutler

    Research Article 25 January 2019 Pages: 331 - 341

    

11. Bystander effectors of chondrosarcoma cells irradiated at different LET impair proliferation of chondrocytes

    • Charlotte Lepleux
    • Aurélie Marie-Brasset
    • François Chevalier

    Research Article Open access 22 March 2019 Pages: 343 - 356

    

12. mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

    • Dorota Ciołczyk-Wierzbicka
    • Marta Zarzycka
    • Piotr Laidler

    OriginalPaper Open access 08 March 2019 Pages: 357 - 368

    

13. TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation

    • Sheng-Jun Liao
    • Jing Luo
    • Zuo-Hua Feng

    Research Article 09 February 2019 Pages: 369 - 380

    

14. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators

    • Wojciech Solarek
    • Michal Koper
    • Anna M. Czarnecka

    Research Article Open access 30 March 2019 Pages: 381 - 394

    

15. CLDN10 promotes a malignant phenotype of osteosarcoma cells via JAK1/Stat1 signaling

    • Xiaowei Zhang
    • Xianbin Wang
    • Tao Li

    Research Article 22 February 2019 Pages: 395 - 405

    

16. Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer

    • Priyanka Ray
    • Gauthami Nair
    • Mohiuddin Quadir

    Research Article 26 March 2019 Pages: 407 - 420

    

17. Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma

    • Afak Rasheed Salman Zaidi
    • Sadie Dresman
    • Lynn McCallum

    Research Article 21 November 2018 Pages: 421 - 434

    

18. Correction to: The official unified nomenclature adopted by the HGNC calls for the use of the acronyms, CCN1–6, and discontinuation in the use of CYR61, CTGF, NOV and WISP 1–3 respectively

    • Bernard Perbal
    • Susan Tweedie
    • Elspeth Bruford

    Correction 29 August 2019 Pages: 435 - 435